Skip to the stories
Saturday, 21 November 2026
Saved

Next edition

19:33

White House

White House withdraws Heidi Overton nomination for FDA commissioner

The Trump administration has withdrawn the nomination of Dr Heidi Overton to lead the Food and Drug Administration, drawing criticism from Senate committee leadership.

FTMQ Politics, written by our newsroom0 views

Share
Picture: Politico White House

The Trump administration has withdrawn the nomination of Dr Heidi Overton to serve as commissioner of the Food and Drug Administration. BioPharma Dive, CIDRAP, MassDevice, Pharmaceutical Executive, pharmaphorum, and FirstWord Pharma all reported that the White House pulled the pick ahead of a Senate vote. Senate Health Committee Chair Bill Cassidy criticized the action. According to Politico, Senator Cassidy claimed he was blindsided after addressing senators' concerns regarding abortion and MAHA. [1][2][3][4][7][8][9][10]

The decision came as the Senate Health Committee prepared to consider the appointment. Senator Cassidy stated that the administration abandoned a viable confirmation path for Dr Overton, according to The Hill. Politico and The Hill both reported that Senator Cassidy believed Dr Overton probably had the votes necessary to be confirmed. [1][2]

As FTMQ Politics reported earlier, the Senate Health Committee was scheduled to vote on Dr Overton's nomination on November 18. The Food and Drug Administration operates as an agency within the United States Department of Health and Human Services. [13]

Senator Cassidy called the White House decision odd after he had worked to address concerns among fellow senators. The White House has not publicly detailed its full reasoning for pulling the nomination before the committee could hold its vote. [1][2]

Share

In short

  • The White House withdrew the nomination of Dr Heidi Overton to lead the Food and Drug Administration.
  • Senate Health Committee Chair Bill Cassidy said Dr Overton probably had enough votes to pass.
  • Senator Cassidy had worked to resolve concerns among senators regarding abortion and MAHA.
  • The Senate Health Committee was scheduled to vote on the nomination on November 18.

Sources

Every paragraph above points to the numbered items it rests on. Read the originals here.

  1. [1]Cassidy slams White House for pulling FDA nominee who ‘probably had the votes’Politico White House, 2d ago (the report this story comes from)
  2. [2]Cassidy questions ‘odd’ White House move in pulling FDA nomineeThe Hill, 2d ago
  3. [3]White House pulls Overton’s nomination for FDA commissionerMassDevice, 2d ago
  4. [4]White House pulls nomination for FDA nominee OvertonBioPharma Dive, 2d ago
  5. [5]As overdose deaths fall, White House makes misleading claims about who deserves creditNPR Politics, 2d ago
  6. [6]US senators urge White House AI chief to fix vulnerabilities after mass outagesThe Guardian, 2d ago
  7. [7]White House pulls Heidi Overton’s nomination for FDA chiefCIDRAP, 2d ago
  8. [8]White House drops Heidi Overton pick for FDA chiefpharmaphorum, 3d ago
  9. [9]White House Withdraws Dr. Heidi Overton’s Nomination as FDA Commissioner: ReportPharmaceutical Executive, 2d ago
  10. [10]White House withdraws Overton's FDA nomination ahead of Senate vote: reportFirstWord Pharma, 3d ago

Background

  1. [11]All In (2023) on Wikipedia
  2. [12]Cassidy on Grokipedia
  3. [13]Senate committee faces vote on Trump FDA nominee Dr Heidi Overton FTMQ Politics, 5d ago

Our newsroom writes these reports with the help of software, from the 13 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.

Earlier reports of ours on the same people and subjects.

More in White House

Get the day in one email

Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments

Loading

Join the conversation

Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.

Already on the list? Enter the same address and we will send a sign-in link.

By signing up you agree to our terms and privacy policy. Unsubscribe any time.